Sym015 MET

Sym015 is a novel combination of two antibodies directed at the elimination of MET receptor, a tyrosine kinase receptor believed to regulate multiple cellular processes that stimulate cell proliferation, invasion and angiogenesis. Sym015 is currently in a Phase 1B trial in patients with MET amplified tumors.